IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.

MLA

Gasilina, Anjelika, et al. “IODVA1, a Guanidinobenzimidazole Derivative, Targets Rac Activity and Ras-Driven Cancer Models.” PloS One, vol. 15, no. 3, Mar. 2020, p. e0229801. EBSCOhost, https://doi.org/10.1371/journal.pone.0229801.

APA

Gasilina, A., Premnauth, G., Gurjar, P., Biesiada, J., Hegde, S., Milewski, D., Ma, G., Kalin, T. V., Merino, E., Meller, J., Seibel, W., Cancelas, J. A., Vinnedge, L. P., & Nassar, N. N. (2020). IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models. PloS One, 15(3), e0229801. https://doi.org/10.1371/journal.pone.0229801

Chicago

Gasilina, Anjelika, Gurdat Premnauth, Purujit Gurjar, Jacek Biesiada, Shailaja Hegde, David Milewski, Gang Ma, et al. 2020. “IODVA1, a Guanidinobenzimidazole Derivative, Targets Rac Activity and Ras-Driven Cancer Models.” PloS One 15 (3): e0229801. doi:10.1371/journal.pone.0229801.